First Medical Genomics course held at IARC
The team organized the first-ever medical genomics course at IARC. The course welcomed 19 participants with diverse backgrounds in bioinformatics and medicine, from IARC, the CanBioS doctoral program, and INSA Lyon Engineering School. It offered an intensive one-week training on cutting-edge sequencing technologies (single-cell, spatial), Artificial Intelligence, and multi-modal data integration. Participants also had the
Presentations at the 2024 NETRF symposium in Boston
Matthieu Foll and Nicolas Alcala were invited to present at the 2024 NETRF symposium. They presented interim results from the lungNENomics project, in particular about the use of AI for diagnosis and the impact of the immune system on neuroendocrine tumor evolution. See videos of the presentations here and here. Thanks a lot to the
Welcome to Ms Yuliya Lim, joining the team for a PhD
We are thrilled to Welcome Yuliya Lim as a PhD student in the team, under the supervision of Nicolas Alcala, Lynnette Fernandez-Cuesta, and Matthieu Foll! Yuliya is the recipient of a competitive PhD fellowship from the French League Against Cancer and will work on deciphering the mysteries of cancer ecosystem complexity.
Welcome back to Ms Lipika Kalson
We welcome back Lipika for a few months! Lipika is a PhD student in Bioinformatics from the Brcic’s research team in Medizinische Universität Graz, Austria. We are collaborating with Lipika on the multi-omics characterization of Malignant Peritoneal Mesothelioma.
Award from Worldwide Cancer Research
Nicolas Alcala received a grant from Worldwide Cancer Research (WCR) with collaborator Jaehee Kim from the computational biology department at Cornell University, USA (see lab website). The project will combine novel sequencing technologies and mathematical models to study how malignant pleural mesothelioma cells cooperate and compete within a tumor and determine patient’s clinical course. The
The RCG team hosts Prof Alex Di Genova for a week
We had the pleasure to have the visit of Prof Alex Di Genova, former RCG postdoc who is now an associate professor at O’Higgins University (Chile, https://digenoma-lab.cl/author/alex-di-genova/). Alex is now leading several large scale genomics initiative in Chile, including the first chilean genome, and cancer genomics in understudied populations.
Computational Biology of Cancer 2024 conference
Matthieu Foll was a keynote speaker at BioSyl Computational Biology of Cancer 2024 conference, Grenoble (France) with a presentation entitled “Understanding cancer biology through multi- omics genotype-phenotype tumour maps.”
ESMO Sarcoma and Rare Cancers Congress 2024
Matthieu Foll presented a proffered paper at the ESMO Sarcoma and Rare Cancers Congress 2024, Lugano (Switzerland) “The Rare Cancers EPIC database: a gateway to rare cancer epidemiological research.”
The RCG team welcomes Lisa Bonheme
We are thrilled to welcome Lisa as a postdoctoral researcher. Lisa recently obtained her PhD from Kent University on disentangled representations learning and variational auto-encoders. She will be developing innovative deep-learning models to identify morphological features from whole slide images associated with tumor aggressiveness.
Mentored award from the Neuroendocrine tumor research foundation
Nicolas Alcala received a mentored award from the Neuroendocrine tumor research foundation (NETRF), with Lynnette Fernandez-Cuesta—herself recipient of a NETRF investigator award in 2019—as mentor. The project will consist in using next-generation sequencing data to study how the DNA of tumors and the patient’s immune response interact to determine a patient’s tumor molecular subtype and